Ken Griffin Gh Research PLC Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Gh Research PLC stock. As of the latest transaction made, Citadel Advisors LLC holds 3,200 shares of GHRS stock, worth $24,960. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,200
Previous 200
1500.0%
Holding current value
$24,960
Previous $2,000
1750.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding GHRS
# of Institutions
34Shares Held
23.5MCall Options Held
63.1KPut Options Held
1.9K-
Bvf Inc San Francisco, CA10.4MShares$81.1 Million3.71% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.6MShares$51.5 Million1.16% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$26 Million0.65% of portfolio
-
Verition Fund Management LLC Greenwich, CT1.14MShares$8.9 Million0.08% of portfolio
-
Cormorant Asset Management, LP Boston, MA593KShares$4.63 Million0.53% of portfolio
About GH Research PLC
- Ticker GHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,020,800
- Market Cap $406M
- Description
- GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...